PHK
OMIC

Point72 Hong Kong’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Point72 Hong Kong’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-63
Closed -$12K – 2511
2022
Q1 		$12K Buy
+63
New +$14.6K ﹤0.01% 1588

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Point72 Hong Kong's OMIC Position: Q2 2022 in Review

Point72 Hong Kong sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2022, closing a stake of 63 shares — an estimated $12K sold.

Point72 Hong Kong first reported a position in OMIC in Q1 2022 and held it in 1 quarter. The position peaked at $12K in Q1 2022. 76 funds tracked by Wall St. Rank hold OMIC as of Q2 2022.

  • Point72 Hong Kong reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 63 Singular Genomics Systems, Inc. Common Stock shares in Q2 2022, an estimated $12K.
  • Point72 Hong Kong first reported a position in Singular Genomics Systems, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Point72 Hong Kong's Singular Genomics Systems, Inc. Common Stock position peaked at $12K in Q1 2022.
  • 76 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.